IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
1.100
-0.010 (-0.90%)
Feb 21, 2025, 4:00 PM EST - Market closed
IO Biotech Employees
IO Biotech had 68 employees as of December 31, 2023. The number of employees increased by 11 or 19.30% compared to the previous year.
Employees
68
Change (1Y)
11
Growth (1Y)
19.30%
Revenue / Employee
n/a
Profits / Employee
-$1,328,529
Market Cap
72.47M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 68 | 11 | 19.30% |
Dec 31, 2022 | 57 | 25 | 78.13% |
Dec 31, 2021 | 32 | 21 | 190.91% |
Dec 31, 2020 | 11 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
IOBT News
- 2 days ago - IO Biotech to Present at the 45th Annual Cowen Health Care Conference - GlobeNewsWire
- 18 days ago - IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate - GlobeNewsWire
- 6 weeks ago - IO Biotech Completes Enrollment in Phase 2 Trial of its Investigational, Off-the-shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients with Resectable Melanoma or Head and Neck Cancer - GlobeNewsWire
- 2 months ago - IO Biotech secures up to €57.5 million in debt financing from the European Investment Bank - GlobeNewsWire
- 3 months ago - IO Biotech Reports Third Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewsWire
- 3 months ago - IO Biotech Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - IO Biotech Reports its Off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, in Combination with KEYTRUDA® Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Study - GlobeNewsWire
- 5 months ago - IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting - GlobeNewsWire